Company: MLTX
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001140361-25-014923
Chunk: 41

Company: MoonLake Immunotherapeutics
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 41
---
 schedule: (i) 25% of the shares vested on January 18, 2023 and (ii) 2.08% of the shares vest each month thereafter until fully vested. Until such shares fully vest, MoonLake AG may repurchase such shares at a repurchase price equal to such nominal value in the event the employment of the respective officer terminates. |

Option Exercises and Stock Vested Table The following table sets forth information regarding the stock awards vested for our named executive officers during fiscal 2024. None of our named executive officers exercised any stock options during 2024.

|                           |     |    Stock Awards |     |                |
| Name                      |     |       Number of 
 Shares Acquired 
      on Vesting 
             (#) |     | Value Realized 
     on Vesting 
            ($) |
| Dr. Jorge Santos da Silva |     |          83,962 |     |      4,067,338 |
| Matthias Bodenstedt       |     |         125,943 |     |      6,101,008 |
| Dr. Kristian Reich        |     |          83,962 |     |      4,067,338 |

Fiscal Year 2024 Pension Benefits The following table sets forth the pension benefits of the named executive officers as of December 31, 2024.

| Name                      |     | Plan Name              |     | Number of Years of 
   Credited Service 
                (#) |     |    Present Value of 
 Accumulated Benefit 
                 ($) |     | Payments During  
 Last Fiscal Year 
 ($)              |
| Dr. Jorge Santos da Silva |     | MoonLake AG Swiss Plan |     |                3.5 |     |             573,576 |     | —                |
| Matthias Bodenstedt       |     | MoonLake AG Swiss Plan |     |                3.5 |     |             260,581 |     | —                |

MoonLake AG Swiss Plan The MoonLake AG Swiss Plan complies with Swiss tax requirements applicable to broad-based pension plans. Normal retirement age under the MoonLake AG Swiss Plan is 65, for men, and 64, for women. All benefits are immediately vested.

27

TABLE OF CONTENTS Under the MoonLake AG Swiss Plan, 15% of pensionable salary is contributed as retirement credit with additional contributions for death and disability benefits. MoonLake AG makes 50% of the contributions, and the covered employee makes